Skip to content

HYPERBARIC OXYGEN THERAPY AS AN ANTI - AGING TREATMENT COMPARED TO PEELS/BOTOX

COMPARATIVE STUDY OF ROLE OF HYPERBARIC OXYGEN THERAPY VERSUS TRADITIONAL MODALITIES FOR ANTI - AGING THERAPY

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059268
Enrollment
24
Registered
2023-10-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: HYPERBARIC OXYGEN THERAPY: HBOT involves breathing of 100% oxygen while in a special chamber called a hyperbaric chamber with increased air pressure.

Sponsors

KING GEORGE MEDICAL UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy male or female subjects aged 30 years to 50 years. 2.Subjects willing to undergo intervention for aesthetic purposes.

Exclusion criteria

Exclusion criteria: 1.Patients with immune deficiency diseases and disorders. Patients with contraindication of HBOT 2.Congestive heart failure. 3.Patient with Pacemakers. 4.Subjects who had undergone any medical aesthetic procedures (eg, chemical peeling, botulinum toxic injection, dermal fillers, laser resurfacing, electrosurgery, etc.) at least 1 year prior to the study entry.

Design outcomes

Primary

MeasureTime frame
To evaluate the role of hyperbaric oxygen therapy (HBOT) in attenuating or reversing the signs of aging. •To compare HBOT with traditional modalities such as Botox and peels for anti aging. Modified Fitzpatrick scale would be used to assess the changes.Timepoint: O , 30, 60 DAYS OF RECIEVING HBOT AND 4 WEEKS AFTER COMPLETION OF HBOT

Secondary

MeasureTime frame
Subjective evaluation of patient satisfaction with HBOT as an antiageing modalityTimepoint: 4 weeks Post HBOT

Countries

India

Contacts

Public ContactDR MEHVASH KHAN

KING GEORGE’S MEDICAL UNIVERSITY, LUCKNOW

vijaykgmu@gmail.com9415085625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026